Clinical Trial Update: Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for midostaurin in aggressive systemic mastocytosis and mast cell leukemia has completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Systemic Mastocytosis
• Hematological Non-mast Cell Lineage Disease
• Mast Cell Leukemia
• Systemic Mastocytosis

Drugs mentioned

• Midostaurin (midostaurin)

Snippet

Sponsor: Jason Robert Gotlib | Conditions: Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell | Phase 2 | Status: COMPLETED | Results posted: 2015-07-09